House Energy and Commerce Committee advances mental health bills; addresses MIEP for juveniles

Image of GettyImages-1132100986-1.jpg

Key Takeaways

On May 18, the U.S. House Energy and Commerce Committee advanced six bipartisan bills out of committee. Two of the six bills would support key mental health programs for counties: the Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666) and the Keeping Incarceration Discharges Streamlined for Children and Accommodating Resources in Education Act (KIDS CARES Act) (H.R. 7233).

If enacted, H.R. 7666 would reauthorize over 30 key programs under the Health Resources and Services (HRSA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) that are due to expire at the end of Fiscal Year 2022 on October 1, 2022. Key provisions in the bill include:

  • Reauthorization of SAMHSA’s Community Mental Health Services (CMHS) and the Substance Use Prevention, Treatment and Recovery Services Block grant programs, including a new requirement that 5 percent of funds in the CMHS block grant be allocated toward crisis care services
  • Reauthorization of HRSA’s Screening and Treatment for Maternal Mental Health and Substance Use Disorder grant program and the establishment of a maternal mental health hotline
  • Elimination of the requirement that an individual be addicted to opioids for at least one year prior to being admitted for treatment by an opioid treatment program

Other key highlights include:

  • $10 million in grants to states for the implementation of mental health and substance use disorder service parity.
  • The elimination of federal approval requirements for the administration of certain medication assisted treatment.
  • Grants to local entities to develop, expand, and enhance access to peer-delivered mental health services.

Additionally, H.R. 7233 – which was passed with unanimous support – would require state Medicaid agencies to cover mental health screenings for justice-involved youth. Most notably, a bipartisan amendment to the bill would advance a key priority for counties through the removal of the Medicaid inmate exclusion policy (MIEP) for juveniles pending disposition of charges. This provision supports a long-standing county policy priority to amend the MIEP for pre-trial detainees, given the detrimental impact of this policy on access to health services and behavioral health treatment.

As key administrators of local behavioral health services, counties applauded the introduction of the H.R. 7666. In response to the package, NACo sent a letter to committee leadership outlining additional measures for improving the provision of behavioral health services in counties. We will continue to work collaboratively with congressional policy makers to advance these and other policies that will improve and increase access to mental and behavioral health services for county residents.

Click here to view the full list of bills and amendments considered. The bill now moves to the full House for a floor vote in the coming weeks.

Additional Resources

Tagged In:

Related News

Image of Capitol-panorama_2.jpg
Advocacy

U.S. Senate passes amended reconciliation bill text: What it means for counties

On July 1, the U.S. Senate narrowly passed their version of sweeping budget reconciliation legislation.

THE_County Countdown_working_image-4.png
Advocacy

County Countdown – June 30, 2025

Every other week, NACo's County Countdown reviews top federal policy advocacy items with an eye towards counties and the intergovernmental partnership. This week features the Senate reconciliation debate, transparency on sanctuary designations and more.

bike
Advocacy

NACo submits recommendations on the 2026 National Drug Control Strategy

On June 20, NACo submitted formal comments to the White House Office of National Drug Control Policy (ONDCP) to help shape the development of its 2026 National Drug Control Strategy. This strategy serves as the nation’s blueprint for reducing illicit drug use, and the ONDCP plays a central role in coordinating federal drug policy across government agencies.